Abstract:Glioblastoma (GBM) invasion studies have focused on coding genes, while few studies evaluate long non-coding RNAs (lncRNAs), transcripts without protein-coding potential, for role in GBM invasion. We leveraged CRISPR-interference (CRISPRi) to evaluate invasive function of GBM-associated lncRNAs in an unbiased functional screen, characterizing and exploring the mechanism of identified candidates. We implemented a CRISPRi lncRNA loss-of-function screen evaluating association of lncRNA knockdown (KD) with invasion capacity in Matrigel. Top screen candidates were validated using CRISPRi and oligonucleotide(ASO)-mediated knockdown in three tumor lines. Clinical relevance of candidates was assessed via The Cancer Genome Atlas(TCGA) and Genotype-Tissue Expression(GTEx) survival analysis. Mediators of lncRNA effect were identified via differential expression analysis following lncRNA KD and assessed for tumor invasion using knockdown and rescue experiments. Forty-eight lncRNAs were significantly associated with 33–83% decrease in invasion (p<0.01) upon knockdown. The top candidate, LINC03045 , identified from effect size and p-value, demonstrated 82.7% decrease in tumor cell invasion upon knockdown, while LINC03045 expression was significantly associated with patient survival and tumor grade(p<0.0001). RNAseq analysis of LINC03045 knockdown revealed that WASF3 , previously implicated in tumor invasion studies, was highly correlated with lncRNA expression, while WASF3 KD was associated with significant decrease in invasion. Finally, WASF3 overexpression demonstrated rescue of invasive function lost with LINC03045 KD. CRISPRi screening identified LINC03045 , a previously unannotated lncRNA, as critical to GBM invasion. Gene expression is significantly associated with tumor grade and survival. RNA-seq and mechanistic studies suggest that this novel lncRNA may regulate invasion via WASF3 . Glioblastoma is the most common malignant brain tumor to originate from brain tissue in adults. Most research has focused on the role of genes that code for protein, but genes that do not code for protein can still produce long non-coding RNAs (lncRNAs) that have been demonstrated to have important functions in cancer processes. We utilized a method called CRISPRi to screen for lncRNAs that are important in glioblastoma invasion, which is the capacity of cancer cells to invade into surrounding tissue. With this CRISPRi invasion screen, we identified LINC03045 as a gene that affects glioblastoma invasion. We validated this finding using cultured cancer stem cells and found that knocking down this gene decreased invasion. We also analyzed the public databases for clinical relevance, and found that LINC03045 was associated with patient survival and tumor grade. We also identified the gene WASF3 , previously implicated in multiple tumor invasion studies (an element of the JAK-STAT pathway) as a downstream element of LINC03045 . Thus, here, we have identified LINC03045 as a critical non-coding gene in glioblastoma invasion, and further characterizing this gene could potentially make it a therapeutic target for glioblastoma therapy in the future.

Long Noncoding RNA LINC00346 Promotes Glioma Cell Migration, Invasion and Proliferation by Up-Regulating ROCK1.

Long Noncoding RNA LINC00052 Suppressed the Proliferation, Migration and Invasion of Glioma Cells by Upregulating KLF6.

Long Non‑coding RNA LINC00473/miR‑195‑5p Promotes Glioma Progression Via YAP1‑TEAD1‑Hippo Signaling.

Long Noncoding RNA Lncherg Promotes Cell Proliferation, Migration and Invasion in Glioblastoma

Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16

Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma

Long intergenic non-coding LINC00657 regulates tumorigenesis of glioblastoma by acting as a molecular sponge of miR-190a-3p.

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma

The Effect and Mechanism of LINC00663 on the Biological Behavior of Glioma

lncRNA LINC00355 Acts as a Novel Biomarker and Promotes Glioma Biological Activities via the Regulation of miR-1225/FNDC3B

Long noncoding RNA LINC00941 promotes pancreatic cancer progression by competitively binding miR-335-5p to regulate ROCK1-mediated LIMK1/Cofilin-1 signaling

LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis

Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion.

LncRNA LINC01018/miR‐942‐5p/KNG1 Axis Regulates the Malignant Development of Glioma in Vitro and in Vivo

Long Non-Coding RNA LINC00339 Facilitates the Tumorigenesis of Non-Small Cell Lung Cancer by Sponging Mir-145 Through Targeting FOXM1.

Long Noncoding RNA SNHG3 Promotes Glioma Tumorigenesis by Sponging Mir‐485‐5p to Upregulate LMX1B Expression

LINC00883 Promotes Drug Resistance of Glioma Through a microRNA-136/NEK1-Dependent Mechanism

<i>LINC01123</i> potentially correlates with radioresistance in glioma through the <i>miR-151a/CENPB</i> axis

Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p

CRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion

LncRNA DLGAP1‐AS1 Accelerates Glioblastoma Cell Proliferation Through Targeting Mir‐515‐5p/rock1/nfe2l1 Axis and Activating Wnt Signaling Pathway